{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:45:48Z","timestamp":1787949948803,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejca.2022.12.032","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T23:01:49Z","timestamp":1674169309000},"page":"144-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate\/poor prognosis: A multi-institutional retrospective cohort study"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-5497","authenticated-orcid":false,"given":"Luca","family":"Antonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ardizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-4702","authenticated-orcid":false,"given":"Praful","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Bagrodia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6224-9598","authenticated-orcid":false,"given":"Siamak","family":"Daneshmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Nazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Franza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2511-3664","authenticated-orcid":false,"given":"Axel","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Paffenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragheed","family":"Saoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Eggener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-214X","authenticated-orcid":false,"given":"Alexey","family":"Tryakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5615-7806","authenticated-orcid":false,"given":"Mikhail","family":"Fedyanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-6869","authenticated-orcid":false,"given":"Natacha","family":"Naoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Javaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Fizazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Adra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoin","family":"Douglawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-5488","authenticated-orcid":false,"given":"Christian D.","family":"Fankhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib1","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.032_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"issue":"34","key":"10.1016\/j.ejca.2022.12.032_bib3","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib4","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1200\/JCO.1998.16.4.1287","article-title":"Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study","volume":"16","author":"Nichols","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2022.12.032_bib5","series-title":"EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam","isbn-type":"print","year":"2022","ISBN":"https:\/\/id.crossref.org\/isbn\/9789492671165"},{"key":"10.1016\/j.ejca.2022.12.032_bib6","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Testicular Cancer Version 2.2022 \u2014 January 4, 2022."},{"issue":"2","key":"10.1016\/j.ejca.2022.12.032_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.euo.2020.08.007","article-title":"Long-term surveillance of patients with complete response following chemotherapy for metastatic nonseminomatous germ cell tumor","volume":"4","author":"Nason","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.032_bib8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdt425","article-title":"A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor","volume":"25","author":"Ravi","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.2009.23.0755","article-title":"Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery","volume":"28","author":"Kollmannsberger","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4S","key":"10.1016\/j.ejca.2022.12.032_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-5347(18)31070-X","article-title":"830: clinical outcome following post-chemotherapy retroperitoneal lymph node dissection for men with CII non-seminomatous germ cell tumors and a radiographically normal retroperitoneum","volume":"177","author":"Karellas","year":"2007","journal-title":"J Urol"},{"issue":"17","key":"10.1016\/j.ejca.2022.12.032_bib12","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1992.10.4.569","article-title":"Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?","volume":"10","author":"Fossa","year":"1992","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.ejca.2022.12.032_bib14","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","article-title":"Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"21","author":"Oldenburg","year":"2003","journal-title":"J Clin Oncol"},{"issue":"suppl 7","key":"10.1016\/j.ejca.2022.12.032_bib15","article-title":"Pathohistologic findings in patients with nonseminomatous germ cell tumors (NSGCT) who undergo postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for small tumors","volume":"29","author":"Pfister","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.12.032_bib16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.1990.8.10.1683","article-title":"Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection","volume":"8","author":"Toner","year":"1990","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.2009.23.0714","article-title":"Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?","volume":"28","author":"Ehrlich","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2022.12.032_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1331::AID-CNCR16>3.0.CO;2-I","article-title":"Resection of small, residual retroperitoneal masses after chemotherapy for nonseminomatous testicular cancer: a decision analysis","volume":"85","author":"Steyerberg","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2022.12.032_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0022-5347(18)31071-1","article-title":"High rate of retroperitoneal teratoma despite complete remission after chemotherapy for metastatic nonseminomatous germ cell tumor","volume":"177","author":"Steiner","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ejca.2022.12.032_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0022-5347(09)60925-3","article-title":"Post-chemotherapy retroperitoneal lymph node dissection for testicular germ cell tumors: is surgery indicated in all and is bilateral template necessary? Princess Margaret Hospital experience","volume":"181","author":"Kakiashvili","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.ejca.2022.12.032_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000002751","article-title":"Surveillance after complete response to first-line chemotherapy in patients with metastatic nonseminomatous germ cell tumor","author":"King","year":"2022","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.032_bib22","doi-asserted-by":"crossref","first-page":"136 e11","DOI":"10.1016\/j.urolonc.2020.11.026","article-title":"Surveillance of postchemotherapy subcentimeter residual retroperitoneal mass in metastatic nonseminomatous germ cell tumor: does how you measure matter?","volume":"39","author":"Cotner","year":"2021","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.12.032_bib23","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","article-title":"Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group","volume":"19","author":"Fizazi","year":"2001","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.ejca.2022.12.032_bib24","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1200\/JCO.2005.21.956","article-title":"Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy","volume":"23","author":"Ronnen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.12.032_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ucl.2015.04.010","article-title":"Late relapse of testicular germ cell tumors","volume":"42","author":"O'Shaughnessy","year":"2015","journal-title":"Urol Clin North Am"},{"issue":"9","key":"10.1016\/j.ejca.2022.12.032_bib26","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.21873\/anticanres.13678","article-title":"Somatic transformation in metastatic testicular germ cell tumours - a different disease entity","volume":"39","author":"Sharma","year":"2019","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.ejca.2022.12.032_bib27","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.urolonc.2008.10.026","article-title":"Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer","volume":"28","author":"Subramanian","year":"2010","journal-title":"Urol Oncol"},{"issue":"3 Pt 2","key":"10.1016\/j.ejca.2022.12.032_bib28","first-page":"976","article-title":"Complications of post-chemotherapy retroperitoneal lymph node dissection","volume":"153","author":"Baniel","year":"1995","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jjco\/hyu001","article-title":"Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma","volume":"44","author":"Endo","year":"2014","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.032_bib30","first-page":"26","article-title":"Use of imaging for active surveillance in testicular cancer: is real-world practice concordant with guidelines?","volume":"16","author":"Gyawali","year":"2022","journal-title":"Can Urol Assoc J"},{"issue":"7","key":"10.1016\/j.ejca.2022.12.032_bib31","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1007\/s00330-019-06148-1","article-title":"Actual frequency of imaging during follow-up of testicular cancer in Israel-a comparison with the guidelines","volume":"29","author":"Lehnich","year":"2019","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.032_bib32","first-page":"188","article-title":"Frequency of computed tomography examinations in the follow-up care of testicular cancer patients - an evaluation of patterns of care in Germany","volume":"36","author":"Rusner","year":"2013","journal-title":"Onkologie"},{"issue":"9b","key":"10.1016\/j.ejca.2022.12.032_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1464-410X.2009.08861.x","article-title":"Retroperitoneal lymph node dissection: reassessment of modified templates","volume":"104","author":"Large","year":"2009","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.032_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.eururo.2008.09.027","article-title":"Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection","volume":"55","author":"Heidenreich","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.032_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/bju.13844","article-title":"Modified retroperitoneal lymph node dissection for post-chemotherapy residual tumour: a long-term update","volume":"120","author":"Cho","year":"2017","journal-title":"BJU Int"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:40:00Z","timestamp":1760733600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":35,"alternative-id":["S0959804923000102"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.12.032","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate\/poor prognosis: A multi-institutional retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}